Latest Mrna Podcast Episodes
Roberto Orecchia on the ELIOT trial
The Lancet Oncology in conversation with - April 28, 2021 22:00 - 6 minutes ★★★★★ - 1 ratingRoberto Orecchia (European Institute of Oncology IRCCS) discusses the ELIOT trial on intraoperative irradiation for early breast cancer. Read the full article: https://www.thelancet.com/journals/lanonc/article/PIIS1470-2045(21)00080-2/fulltext Tell us what you thought about this episode Conti...
Hedvig Hricak, Andrew Scott, Rifat Atun, and May Abdel-Wahab on nuclear medicine
The Lancet Oncology in conversation with - March 31, 2021 10:00 - 28 minutes ★★★★★ - 1 ratingHedvig Hricak (Memorial Sloan Kettering Cancer Center), Andrew Scott (Olivia Newton-John Cancer Research Institute), Rifat Atun (Harvard TH Chan School of Public Health), and May Abdel-Wahab (International Atomic Energy Agency) discuss the latest Lancet Oncology’s Commission on Medical Imaging a...
Ariana Znaor on breast and cervical cancer in the former Soviet Union
The Lancet Oncology in conversation with - March 01, 2021 23:00 - 9 minutes ★★★★★ - 1 ratingAriana Znaor, International Agency for Research on Cancer, discusses her Article on breast and cervical cancers stage distributions in ten newly independent states of the former Soviet Union. Read the full article: https://www.thelancet.com/journals/lanonc/article/PIIS1470-2045(20)30674-4/fullt...
Sathira Perera on global cancer surgery
The Lancet Oncology in conversation with - January 21, 2021 23:00 - 7 minutes ★★★★★ - 1 ratingSathira Perera (University of New South Wales, Australia) discusses his (and colleagues) Articles on the global use of cancer surgery. Read the full article: https://www.thelancet.com/journals/lanonc/article/PIIS1470-2045(20)30675-6/fulltext Tell us what you thought about this episode Contin...
Short-course radiotherapy for advanced rectal cancer
The Lancet Oncology in conversation with - January 04, 2021 00:00 - 6 minutes ★★★★★ - 1 ratingGeke Hospers (University Medical Center Groningen, The Netherlands) discusses the RAPIDO trial Article published in The Lancet Oncology. Tell us what you thought about this episode Continue this conversation on social! Follow us today at... https://twitter.com/thelancet & https://Twitter.com/T...
The crucial role of oncology nurses in cancer care
The Lancet Oncology in conversation with - November 16, 2020 23:00 - 26 minutes ★★★★★ - 1 ratingAnnie Young (University of Warwick, UK) and Julia Challinor (University of California San Francisco, USA) present their two-paper Series on Oncology Nursing. Tell us what you thought about this episode Continue this conversation on social! Follow us today at... https://twitter.com/thelancet &...
The effect of climate change on cancer control
The Lancet Oncology in conversation with - November 02, 2020 23:00 - 11 minutes ★★★★★ - 1 ratingRobert Hiatt (University of California San Francisco, USA) discusses his and Naomi Beyeler’s (same University) Review on climate change and cancer. Tell us what you thought about this episode Continue this conversation on social! Follow us today at... https://twitter.com/thelancet & https://T...
Adjuvant radiotherapy versus early salvage radiotherapy in prostate cancer
The Lancet Oncology in conversation with - September 29, 2020 07:00 - 16 minutes ★★★★★ - 1 ratingPaul Sargos (Institut Bergonié, France) discusses the GETUG-AFU 17 trial and Andrew Kneebone (Royal North Shore Hospital and University of Sidney, Australia) the RAVES trial. Tell us what you thought about this episode Continue this conversation on social! Follow us today at... https://twitter...
Peptide receptor radionuclide therapy for neuroendocrine tumours
The Lancet Oncology in conversation with - September 05, 2020 08:00 - 19 minutes ★★★★★ - 1 ratingLisa Bodei (Memorial Sloan Kettering Cancer Center, New York, NY, USA) discusses the Review in The Lancet Oncology on molecular profiling of neuroendocrine tumours to predict response to peptide receptor radionuclide therapy. Tell us what you thought about this episode Continue this conversati...
Larotrectinib in patients with TRK fusion-positive solid tumours
The Lancet Oncology in conversation with - April 07, 2020 10:00 - 13 minutes ★★★★★ - 1 ratingAlexander Drilon (Memorial Sloan Kettering Cancer Center, New York, NY, USA) discusses a pooled analysis in The Lancet Oncology on the role of larotrectinib in patients with TRK fusion-positive solid tumours. Tell us what you thought about this episode Continue this conversation on social! Fol...
The future of radiotheranostics
The Lancet Oncology in conversation with - March 11, 2020 06:00 - 7 minutes ★★★★★ - 1 ratingKen Herrman (University Hospital Essen, Essen, Germany) discusses a Review in The Lancet Oncology on the role of injectable radiopharmaceuticals with anti-tumour effects. Tell us what you thought about this episode Continue this conversation on social! Follow us today at... https://twitter.com...
International standards for the analysis of patient-reported outcomes in cancer trials
The Lancet Oncology in conversation with - March 03, 2020 15:30 - 11 minutes ★★★★★ - 1 ratingCorneel Coens and Madeline Pe discuss recommendations from the SISAQOL Consortium for the analysis of patient-reported outcomes, published in a Policy Review in The Lancet Oncology. Tell us what you thought about this episode Continue this conversation on social! Follow us today at... https://...
Presenting symptoms of cancer and stage at diagnosis
The Lancet Oncology in conversation with - January 09, 2020 08:00 - 6 minutes ★★★★★ - 1 ratingMonica Koo (University College London, London, UK) discusses an Article in The Lancet Oncology on presenting symptoms of cancer and stage at diagnosis in patients in England. Tell us what you thought about this episode Continue this conversation on social! Follow us today at... https://twitter...
Global public and philanthropic investment in childhood cancer research
The Lancet Oncology in conversation with - December 04, 2019 08:00 - 14 minutes ★★★★★ - 1 ratingRifat Atun (Harvard T H Chan School of Public Health, Harvard University, Boston, MA, USA) discusses a Review in The Lancet Oncology on global patterns in public and philanthropic funding for childhood cancer research with Senior Editor Márcia Costa. Tell us what you thought about this episode ...
Cervical cancer in India
The Lancet Oncology in conversation with - October 30, 2019 14:00 - 8 minutes ★★★★★ - 1 ratingPartha Basu (International Agency for Research on Cancer, Lyon, France) discusses a Policy Review in The Lancet Oncology on cervical cancer prevention efforts in India. Tell us what you thought about this episode Continue this conversation on social! Follow us today at... https://twitter.com/t...
Oropharyngeal squamous cell carcinoma
The Lancet Oncology in conversation with - October 03, 2019 15:00 - 18 minutes ★★★★★ - 1 ratingDavid Palma and Anthony Nichols discuss the findings from their ORATOR trial on radiotherapy or robotic surgery for oropharyngeal squamous cell carcinoma. Tell us what you thought about this episode Continue this conversation on social! Follow us today at... https://twitter.com/thelancet & htt...
Cancer in small island nations
The Lancet Oncology in conversation with - September 03, 2019 07:00 - 7 minutes ★★★★★ - 1 ratingNew Zealand’s new interim Cancer Control Agency director, Diana Sarfati, discusses a series of five papers exploring cancer control in small island nations. Tell us what you thought about this episode Continue this conversation on social! Follow us today at... https://twitter.com/thelancet & h...
Advances in radioimmunotherapy
The Lancet Oncology in conversation with - August 29, 2019 15:00 - 13 minutes ★★★★★ - 1 ratingEric Deutsch (Gustave Roussy Comprehensive Cancer Center, Villejuif, France) presents The Lancet Oncology’s latest series on advances in radioimmunotherapy for cancer. Tell us what you thought about this episode Continue this conversation on social! Follow us today at... https://twitter.com/th...
International Neoadjuvant Melanoma Consortium
The Lancet Oncology in conversation with - July 02, 2019 06:30 - 13 minutes ★★★★★ - 1 ratingGeorgina Long (The University of Sydney, Sydney, NSW, Australia) discusses three papers from The Lancet Oncology on neoadjuvant approaches for melanoma treatment. Tell us what you thought about this episode Continue this conversation on social! Follow us today at... https://twitter.com/thelanc...
IMWG consensus on imaging in plasma cell disorders
The Lancet Oncology in conversation with - May 29, 2019 07:00 - 7 minutes ★★★★★ - 1 ratingJens Hillengass discusses the new International Myeloma Working Group consensus guidelines on optimal use of imaging methods for monoclonal plasma cell disorders. Tell us what you thought about this episode Continue this conversation on social! Follow us today at... https://twitter.com/thelanc...
Digital oncology
The Lancet Oncology in conversation with - May 16, 2019 00:00 - 9 minutes ★★★★★ - 1 ratingKee Yuan Ngiam (National University Hospital Singapore, Singapore) discusses a duo of papers exploring big data and machine-learning algorithms for healthcare delivery and pathology in oncology. Tell us what you thought about this episode Continue this conversation on social! Follow us today a...
Choosing Wisely India
The Lancet Oncology in conversation with - April 02, 2019 23:00 - 12 minutes ★★★★★ - 1 ratingCS Pramesh discusses ten low-value or harmful practises that should be avoided in cancer care in India. Tell us what you thought about this episode Continue this conversation on social! Follow us today at... https://twitter.com/thelancet & https://Twitter.com/TheLancetOncol https://instagram.c...
Paediatric vertebral radiotherapy
The Lancet Oncology in conversation with - March 05, 2019 23:00 - 14 minutes ★★★★★ - 1 ratingBianca Hoeben discusses the latest guidelines from the SIOPE radiotherapy working group on vertebral radiotherapy dose in paediatric patients. Tell us what you thought about this episode Continue this conversation on social! Follow us today at... https://twitter.com/thelancet & https://Twitter...
Malignant plural mesothelioma
The Lancet Oncology in conversation with - February 02, 2019 07:30 - 20 minutes ★★★★★ - 1 ratingAnna Bibby joins The Lancet Oncology to discuss recent developments in the treament of malignant plural mesothelioma. Tell us what you thought about this episode Continue this conversation on social! Follow us today at... https://twitter.com/thelancet & https://Twitter.com/TheLancetOncol https...
CAR T-cell therapy
The Lancet Oncology in conversation with - January 03, 2019 16:00 - 12 minutes ★★★★★ - 1 ratingFrederick Locke joins The Lancet Oncology to discuss long-term results from the ZUMA-1 trial on the safety and activity of axicabtagene ciloleucel in refractory large B-cell lymphoma. Tell us what you thought about this episode Continue this conversation on social! Follow us today at... https:...
Cervical cancer screening in older women
The Lancet Oncology in conversation with - November 29, 2018 07:30 - 12 minutes ★★★★★ - 1 ratingTalía Malagón discusses her modelling study which assesses the age at which to stop cervical cancer screening in older women and the remaining lifetime risk of cervical cancer. Tell us what you thought about this episode Continue this conversation on social! Follow us today at... https://twitt...
Palliative care in oncology
The Lancet Oncology in conversation with - October 19, 2018 04:00 - 10 minutes ★★★★★ - 1 ratingStein Kaasa and Jon Loge discuss their new Commission on palliative care. Tell us what you thought about this episode Continue this conversation on social! Follow us today at... https://twitter.com/thelancet & https://Twitter.com/TheLancetOncol https://instagram.com/thelancetgroup https://face...
Global review of cancer control
The Lancet Oncology in conversation with - September 27, 2018 06:30 - 10 minutes ★★★★★ - 1 ratingAndre Ilbawi talks about his global analysis of available national cancer control plans with The Lancet Oncology. Tell us what you thought about this episode Continue this conversation on social! Follow us today at... https://twitter.com/thelancet & https://Twitter.com/TheLancetOncol https://i...
Are patient reported outcomes consistent?
The Lancet Oncology in conversation with - August 31, 2018 14:30 - 8 minutes ★★★★★ - 1 ratingA review in The Lancet Oncology asks whether patient reported outcomes in RCTs are consistent across their analysis, reporting, and interpretation. Author Madeline Pe discusses the findings. Tell us what you thought about this episode Continue this conversation on social! Follow us today at......
Changing incidence of adolescent cancer
The Lancet Oncology in conversation with - August 31, 2018 06:30 - 8 minutes ★★★★★ - 1 ratingEva Steliarova-Foucher joins The Lancet Oncology to discuss the Europe-wide Automated Childhood Cancer Information System, and the increase in cancer incidence rates among children and adolescents. Tell us what you thought about this episode Continue this conversation on social! Follow us toda...